Cash Dividend On The Way From Invesco Municipal Income Opportunities Trust (OIA)

Looking at the universe of stocks we cover at Dividend Channel, on 5/9/13, Invesco Municipal Income Opportunities Trust (OIA) will trade ex-dividend, for its monthly dividend of $0.035, payable on 5/31/13. As a percentage of OIA's recent stock price of $7.16, this dividend works out to approximately 0.49%.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for OIA, showing historical dividends prior to the most recent $0.035 declared by Invesco Municipal Income Opportunities Trust:

OIA+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from OIA is likely to continue, and whether the current estimated yield of 5.87% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of OIA shares, versus its 200 day moving average:

Invesco Municipal Income Opportunities Trust 200 Day Moving Average Chart

Looking at the chart above, OIA's low point in its 52 week range is $6.91 per share, with $8.02 as the 52 week high point — that compares with a last trade of $7.15.

In Tuesday trading, Invesco Municipal Income Opportunities Trust shares are currently trading flat on the day.

null

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says